Development of a Bispecific Antibody Targeting CD30 and CD137 on Hodgkin and Reed-Sternberg Cells.

Rajendran, Sakthi; Li, Yating; Ngoh, Evelyn; Wong, Hiu Yi; Cheng, Man Si; Wang, Cheng-I; Schwarz, Herbert

Rajendran, Sakthi; Li, Yating; Ngoh, Evelyn; Wong, Hiu Yi; Cheng, Man Si; Wang, Cheng-I; Schwarz, Herbert.

Afiliação

Rajendran S; Department of Physiology, National University of Singapore, Singapore, Singapore.
Li Y; NUS Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore.
Ngoh E; Department of Physiology, National University of Singapore, Singapore, Singapore.
Wong HY; NUS Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore.
Cheng MS; Singapore Immunology Network, Agency for Science, Technology and Research, Singapore, Singapore.
Wang CI; Department of Physiology, National University of Singapore, Singapore, Singapore.
Schwarz H; NUS Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore.

Front Oncol ; 9: 945, 2019.

Article em En | MEDLINE | ID: mdl-31616638

Palavras-chave

CD137; CD30; Hodgkin lymphoma; bispecific antibodies; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Singapura

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google